• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E1064A 和 H1069Q 突变型铜转运 ATP 酶 ATP7B 的 N 结构域稳定性的差异导致其细胞内特性的显著不同。

Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.

机构信息

Department of Biochemistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

出版信息

J Biol Chem. 2011 May 6;286(18):16355-62. doi: 10.1074/jbc.M110.198101. Epub 2011 Mar 11.

DOI:10.1074/jbc.M110.198101
PMID:21398519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3091241/
Abstract

Wilson disease (WD) is a disorder of copper metabolism caused by mutations in the Cu-transporting ATPase ATP7B. WD is characterized by significant phenotypic variability, the molecular basis of which is poorly understood. The E1064A mutation in the N-domain of ATP7B was previously shown to disrupt ATP binding. We have now determined, by NMR, the structure of the N-domain containing this mutation and compared properties of E1064A and H1069Q, another mutant with impaired ATP binding. The E1064A mutation does not change the overall fold of the N-domain. However, the position of the α1,α2-helical hairpin (α-HH) that houses Glu(1064) and His(1069) is altered. The α-HH movement produces a more open structure compared with the wild-type ATP-bound form and misaligns ATP coordinating residues, thus explaining complete loss of ATP binding. In the cell, neither the stability nor targeting of ATP7B-E1064A to the trans-Golgi network differs significantly from the wild type. This is in a contrast to the H1069Q mutation within the same α-HH, which greatly destabilizes protein both in vitro and in cells. The difference between two mutants can be linked to a lower stability of the α-HH in the H1069Q variant at the physiological temperature. We conclude that the structural stability of the N-domain rather than the loss of ATP binding plays a defining role in the ability of ATP7B to reach the trans-Golgi network, thus contributing to phenotypic variability in WD.

摘要

威尔逊病(WD)是一种由铜转运 ATP 酶 ATP7B 基因突变引起的铜代谢紊乱。WD 的表型变异很大,其分子基础知之甚少。先前的研究表明,ATP7B N 结构域中的 E1064A 突变会破坏 ATP 结合。我们通过 NMR 确定了包含该突变的 N 结构域的结构,并比较了 E1064A 和另一种 ATP 结合受损的突变体 H1069Q 的性质。E1064A 突变不会改变 N 结构域的整体折叠。然而,包含 Glu(1064)和 His(1069)的α1,α2-螺旋发夹(α-HH)的位置发生了变化。与野生型 ATP 结合形式相比,α-HH 的移动产生了更开放的结构,并且使 ATP 配位残基失准,从而完全解释了 ATP 结合的丧失。在细胞中,ATP7B-E1064A 向反式高尔基体网络的稳定性和靶向性与野生型相比没有显著差异。这与同一α-HH 内的 H1069Q 突变形成对比,该突变在体外和细胞内都大大降低了蛋白的稳定性。两种突变体之间的差异可以归因于在生理温度下 H1069Q 变体中α-HH 的稳定性较低。我们得出结论,N 结构域的结构稳定性而不是 ATP 结合的丧失在 ATP7B 到达反式高尔基体网络的能力中起着决定性作用,从而导致 WD 的表型变异。

相似文献

1
Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.E1064A 和 H1069Q 突变型铜转运 ATP 酶 ATP7B 的 N 结构域稳定性的差异导致其细胞内特性的显著不同。
J Biol Chem. 2011 May 6;286(18):16355-62. doi: 10.1074/jbc.M110.198101. Epub 2011 Mar 11.
2
The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.人类铜转运ATP酶ATP7B核苷酸结合域的独特功能特性:威尔逊病突变E1064A、H1069Q、R1151H和C1104F的分析
J Biol Chem. 2004 Aug 27;279(35):36363-71. doi: 10.1074/jbc.M404553200. Epub 2004 Jun 17.
3
The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.不变的组氨酸-1069在威尔逊病蛋白(人类铜转运ATP酶ATP7B)折叠和功能中的作用。
J Biol Chem. 2003 Apr 11;278(15):13302-8. doi: 10.1074/jbc.M300034200. Epub 2003 Jan 27.
4
Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.威尔逊病转运蛋白ATP7B的ATP结合域中的序列变异,在酵母模型系统中影响铜转运。
Hum Mutat. 2008 Apr;29(4):491-501. doi: 10.1002/humu.20674.
5
Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network.引发铜转运 ATP 酶 ATP7B 从反式高尔基体网络中逸出的分子事件。
J Biol Chem. 2012 Oct 19;287(43):36041-50. doi: 10.1074/jbc.M112.370403. Epub 2012 Aug 16.
6
Stability and ATP binding of the nucleotide-binding domain of the Wilson disease protein: effect of the common H1069Q mutation.威尔逊病蛋白核苷酸结合结构域的稳定性和ATP结合:常见H1069Q突变的影响
J Mol Biol. 2008 Nov 28;383(5):1097-111. doi: 10.1016/j.jmb.2008.07.065. Epub 2008 Jul 29.
7
Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.威尔逊病蛋白N结构域的溶液结构:独特的核苷酸结合环境及疾病突变的影响
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5302-7. doi: 10.1073/pnas.0507416103. Epub 2006 Mar 27.
8
Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.分析威尔逊病突变发现,不同 ATP7B 突变体之间的相互作用会改变它们的性质。
Sci Rep. 2020 Aug 10;10(1):13487. doi: 10.1038/s41598-020-70366-7.
9
Diverse functional properties of Wilson disease ATP7B variants.威尔逊病 ATP7B 变异体的多种功能特性。
Gastroenterology. 2012 Apr;142(4):947-956.e5. doi: 10.1053/j.gastro.2011.12.048. Epub 2012 Jan 10.
10
Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.鉴定p38丝裂原活化蛋白激酶(p38 MAPK)和应激活化蛋白激酶(JNK)作为纠正威尔逊病致病ATP7B突变体的新靶点。
Hepatology. 2016 Jun;63(6):1842-59. doi: 10.1002/hep.28398. Epub 2016 Jan 25.

引用本文的文献

1
Functional Screen of Wilson Disease ATP7B Variants Reveals Residual Transport Activities.威尔逊病ATP7B变体的功能筛选揭示了残余转运活性。
Hum Mutat. 2025 Jul 7;2025:7485658. doi: 10.1155/humu/7485658. eCollection 2025.
2
Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson's disease.异常的铜代谢和肝脏炎症导致威尔逊病小鼠模型的神经表现。
J Neuroinflammation. 2024 Sep 27;21(1):235. doi: 10.1186/s12974-024-03178-5.
3
Epidemiology of Wilson's Disease and Pathogenic Variants of the Gene Leading to Diversified Protein Disfunctions.Wilson 病的流行病学和导致多种蛋白质功能障碍的基因的致病变异。
Int J Mol Sci. 2024 Feb 18;25(4):2402. doi: 10.3390/ijms25042402.
4
Response of Fibroblasts from Menkes' and Wilson's Copper Metabolism-Related Disorders to Ionizing Radiation: Influence of the Nucleo-Shuttling of the ATM Protein Kinase.Menkes 病和 Wilson 病相关铜代谢紊乱患者成纤维细胞对电离辐射的反应:ATM 蛋白激酶核穿梭的影响。
Biomolecules. 2023 Dec 5;13(12):1746. doi: 10.3390/biom13121746.
5
Wilson disease-causing mutations in the carboxyl terminus of ATP7B regulates its localization and Golgi exit selectively in the unpolarized cells.ATP7B 羧基末端的威尔逊病致病突变选择性调节非极化细胞中的定位和高尔基体出口。
Metallomics. 2023 Sep 5;15(9). doi: 10.1093/mtomcs/mfad051.
6
A case of Wilson disease with the ATP7B mutation presenting movement disorders.一例伴有ATP7B突变的威尔逊病表现为运动障碍。
Surg Neurol Int. 2021 Jun 28;12:303. doi: 10.25259/SNI_489_2021. eCollection 2021.
7
Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.分析威尔逊病突变发现,不同 ATP7B 突变体之间的相互作用会改变它们的性质。
Sci Rep. 2020 Aug 10;10(1):13487. doi: 10.1038/s41598-020-70366-7.
8
Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy.威尔逊病的管理视角:早期诊断和个体化治疗。
Curr Neuropharmacol. 2021;19(4):465-485. doi: 10.2174/1570159X18666200429233517.
9
Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.导致 ATP1A3 突变疾病严重程度的因素:功能障碍、错误折叠和等位基因竞争。
Neurobiol Dis. 2019 Dec;132:104577. doi: 10.1016/j.nbd.2019.104577. Epub 2019 Aug 16.
10
Genetics and epigenetic factors of Wilson disease.威尔逊病的遗传学和表观遗传因素。
Ann Transl Med. 2019 Apr;7(Suppl 2):S58. doi: 10.21037/atm.2019.01.67.

本文引用的文献

1
Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.受威尔逊病致病突变影响的ATP7B表达降低可通过药理学折叠伴侣4-苯基丁酸酯和姜黄素得到挽救。
Hepatology. 2009 Dec;50(6):1783-95. doi: 10.1002/hep.23209.
2
The binding mode of ATP revealed by the solution structure of the N-domain of human ATP7A.人源 ATP7A N 结构域溶液结构揭示的 ATP 结合模式。
J Biol Chem. 2010 Jan 22;285(4):2537-44. doi: 10.1074/jbc.M109.054262. Epub 2009 Nov 16.
3
Nucleotide recognition by CopA, a Cu+-transporting P-type ATPase.铜离子转运P型ATP酶CopA对核苷酸的识别
EMBO J. 2009 Jun 17;28(12):1782-91. doi: 10.1038/emboj.2009.143. Epub 2009 May 28.
4
Crystallization and preliminary X-ray studies of the N-domain of the Wilson disease associated protein.威尔逊病相关蛋白N结构域的结晶及初步X射线研究
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 1;65(Pt 6):621-4. doi: 10.1107/S1744309109017023. Epub 2009 May 22.
5
Stability and ATP binding of the nucleotide-binding domain of the Wilson disease protein: effect of the common H1069Q mutation.威尔逊病蛋白核苷酸结合结构域的稳定性和ATP结合:常见H1069Q突变的影响
J Mol Biol. 2008 Nov 28;383(5):1097-111. doi: 10.1016/j.jmb.2008.07.065. Epub 2008 Jul 29.
6
Function and regulation of human copper-transporting ATPases.人类铜转运ATP酶的功能与调控
Physiol Rev. 2007 Jul;87(3):1011-46. doi: 10.1152/physrev.00004.2006.
7
Sulfate acts as phosphate analog on the monomeric catalytic fragment of the CPx-ATPase CopB from Sulfolobus solfataricus.硫酸盐在来自嗜热栖热菌的CPx - ATP酶CopB的单体催化片段上充当磷酸盐类似物。
J Mol Biol. 2007 Jun 1;369(2):368-85. doi: 10.1016/j.jmb.2007.03.029. Epub 2007 Mar 20.
8
Wilson's disease: an update.威尔逊氏病:最新进展。
Nat Clin Pract Neurol. 2006 Sep;2(9):482-93. doi: 10.1038/ncpneuro0291.
9
Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.威尔逊病蛋白N结构域的溶液结构:独特的核苷酸结合环境及疾病突变的影响
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5302-7. doi: 10.1073/pnas.0507416103. Epub 2006 Mar 27.
10
Structure of the ATP binding domain from the Archaeoglobus fulgidus Cu+-ATPase.嗜热栖热菌铜离子 -ATP 酶的 ATP 结合结构域结构
J Biol Chem. 2006 Apr 21;281(16):11161-6. doi: 10.1074/jbc.M510708200. Epub 2006 Feb 22.